Spero Therapeutics, Inc. (SPRO) Financials

SPRO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 182.4 million 75.5 million
2023-09-30 107.1 million 53.4 million
2023-06-30 98.9 million 44.1 million
2023-03-31 112.5 million 47.7 million

SPRO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -17.5 million 2.0 million
2023-09-30 15.9 million 1.9 million
2023-06-30 -18.6 million 1.9 million
2023-03-31 -12.9 million 2.2 million

SPRO Net Income

No data available :(

SPRO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 76.3 million - 5.5 million
2023-09-30 93.8 million - 5.8 million
2023-06-30 77.7 million - 6.1 million
2023-03-31 96.3 million 85000 6.4 million

SPRO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 53.1 million
2023-09-30 52.7 million
2023-06-30 52.6 million
2023-03-31 52.5 million

SPRO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 16.5 million 6.4 million -
2023-09-30 - 16.4 million 5.7 million -
2023-06-30 - 9.5 million 6.1 million -
2023-03-31 - 9.0 million 7.3 million -

SPRO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 71.8 million 38000
2023-09-30 25.5 million 108000
2023-06-30 788000 9.5 million
2023-03-31 740000 9.0 million

SPRO

Price: $1.66

52 week price:
0.99
2.00

Payout Ratio Range:
-50.00%
-0.30%

Earnings Per Share: 0.43 USD

P/E Ratio: 3.51

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 179389

Market Capitalization: 88.9 million

Average Dividend Frequency: 4

Links: